About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Study of Milnacipran for the Treatment of Fibromyalgia

Study of Milnacipran for the Treatment of Fibromyalgia

NCT00098124·80 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Forest Laboratories

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR) Criteria

You may not be if

Psychiatric illness
Depression
Suicidal risk
Substance abuse
Pulmonary dysfunction
Renal impairment
Active cardiac disease
Liver disease
Autoimmune disease
Cancer
Sleep apnea
Inflammatory bowel disease

The record

StatusCompleted

PhasePhase 3

Taking part1,200

StartedNov 2004

UpdatedDec 24, 2007

Conditions

Where80

Forest Investigative Site
Birmingham, Alabama, United States
Forest Investigative Site
Mobile, Alabama, United States
Forest Investigative Site
Montgomery, Alabama, United States